bloodthinners

Upload: peteraspegren

Post on 06-Jul-2018

213 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/17/2019 BloodThinners

    1/1

    Copyright 2013 American Medical Association. All rig hts reserved.

    JAMA PATIENT PAGE  | Drug Therapy

    BloodThinners

    Thereare 2 typesofbloodthinners,anticoagulantsandantiplateletdrugs.

    Blood clots cancauseproblemswhenthey preventbloodfromflow-

    ing freely, especially to the heart and brain. Sometimes a doctor

    may not want a patient’s blood to clot as easily and will prescribe

    a blood thinner.

    Conditions That May Benefit From an AntiplateletDrug

    • Heart disease or prior heart attack

    • Blood vessel disease

    • Prior stroke or transient ischemic attacks

    • Diabetes

    • Being overweight or having metabolic syndrome

    • Being a smoker

    • Taking certain other medications

    • Certainoperations, such as angioplasty

    Conditions That May Benefit From an Anticoagulant

    • Atrial fibrillation (abnormal heart rhythm)

    • Prior surgery on a heart valve

    • Congenital (since birth) heart defect

    • Deep vein thrombosis

    • Pulmonary embolism

    • Pulmonary hypertension

    Typesof Blood Thinners

    The2 types ofbloodthinners work indifferentways(Figure).Blood-

    thinningdrugs havebeen usedfor manyyears. Newermedications

    are now available, but they may be more costly or less convenient

    or have other drawbacks compared with older drugs. Some com-

    monly used anticoagulants are heparin, enoxaparin or other low-

    molecular-weight heparins,fondaparinux,and warfarin; neweran-

    ticoagulants are dabigatran, rivaroxaban, and apixaban. Common

    antiplatelets include aspirin, aspirin plus extended-release dipyri-

    damole, clopidogrel, prasugrel, and the newer drug cangrelor.

    Treatment With Blood Thinners

    Antiplatelets are usually given orally. Sometimes, the anticoagulant

    heparin is given continuously through the veins in the hospital.

    Warfarin is started orally while a patient is receiving intravenous

    heparinand is continued after theheparin is stopped. Once the INR

    (internationalnormalizedratio,atestofbloodclotting)isstable,hep-arinis stoppedand thepatient continues to take warfarin after leav-

    ing the hospital. It takes some care to maintain the correct level of 

    warfarin. Patients must keep track of foods they eat that contain vi-

    tamin K,especiallygreenleafyvegetables.Patientstypicallyhavetheir

    bloodtesteddaily,thenmonthly,basedontheINR,whichshowshow

    well the warfarin treatment is reducing blood clotting. Some condi-

    tions require lifelong treatment with blood thinners.

    Insomecircumstances,enoxaparinorfondaparinuxcanbeused

    instead of heparin and/or warfarin. Although they require daily in-

     jections, they do not require routine INR testing of blood clotting.

    If you are prescribed a blood thinner, be sure to tell your doc-

    tor about any other medications you take. And if you are taking a

    blood thinner, you need to be cautious about using over-the-

    countermedicationsor herbal (dietary)supplements.Althoughsome

    new anticoagulants do not interact with vitamin K, their interac-

    tion with other substances hasnot been well studied.

    Forming blood clot

    RE D

    BLOOD

    CELL

    Platelets, a type of blood cell,

    stick together when activated

    and form a plug.

    BLOOD VESSEL

    Antiplatelet drugs work by

    making platelets less able

    to stick together.Anticoagulants work by

    interfering with blood-clotting

    proteins.

    Blood-clotting proteins react

    to form a protein network,

    trapping the platelets and

    strengthening the clot.

    FORMOREINFORMATION

    • National Library of Medicine

    www.nlm.nih.gov/medlineplus/bloodthinners.html 

    www.nlm.nih.gov/medlineplus/bloodclots.html 

    To findthisand previous JAMA Patient Pages,go to thePatient

    Page linkon JAMA’swebsiteat  jama.com. Many areavailable in

    English and Spanish.

    Author: Deborah TolmachSugerman,MSW

    Conflictof InterestDisclosures:Theauthor hascompleted andsubmittedthe

    ICMJE FormforDisclosureof PotentialConflictsof Interest andnonewere

    reported.

    Source: BonowRO etal.Braunwald’sHeart Disease:A Textbookof Cardiovascular 

    Medicine . 9th ed. Philadelphia,PA: Elsevier Sanders; 2012:chap87.

    Correction: This articlewas correctedfor a typo on August6, 2014.

    TheJAMAPatient Pageis a publicservice of  JAMA. Theinformationand

    recommendations appearingon thispage areappropriate in mostinstances,but they

    are nota substitute formedicaldiagnosis. Forspecificinformation concerning your

    personal medical condition, JAMAsuggests thatyou consultyour physician. Thispage

    maybe photocopiednoncommercially by physicians andother health care

    professionalsto sharewith patients. Topurchase bulkreprints, call312/464-0776.

     jama.com   JAMA   December18, 2013 Volume310, Number23   2579

    Copyright 2013 American Medical Association. All rig hts reserved.

    wnloaded From: http://jama.jamanetwork.com/ on 05/01/2015